News
In early corporate news, AstraZeneca receives EU approval for a bladder cancer therapy, and a subdued housing market leaves MJ Gleeson eyeing adjusted pretax profit at the lower end of current market ...
AstraZeneca boss Sir Pascal Soriot (pictured) is thought to be mulling shifting its listing to New York due to growing ...
The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...
10d
InvestorsHub on MSNAstraZeneca shares climb amid rumors CEO prefers U.S. stock listingAstraZeneca PLC (NASDAQ:AZN) saw its American Depositary Receipts (ADRs) increase by 2.2% following a report from The Times ...
In section 899 of the bill, Trump proposed what has become known as a “revenge tax”, which gave him a new power to punish ...
In a press release on June 13, 2025, AstraZeneca announced its entry into a strategic research collaboration with CSPC Pharmaceuticals Group, based in Shijiazhuang City, China (1). The two companies ...
AstraZeneca has put hundreds of millions of dollars into AI deals, with an eye toward not just accelerating the development of drugs that treat cancer after it appears but also in creating diagnostics ...
AstraZeneca PLC (NASDAQ:AZN) Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot - ...
The AstraZeneca property is split by Del. 141. A bridge connects what the firm calls its north and south campuses. The document filed in the county deeds office updates the legal responsibilities ...
Covington & Burling's London operation has advised pharmaceuticals giant AstraZeneca on its $1 billion acquisition of EsoBiotec, a Belgian biotechnology company specialising in vivo cell therapies.
AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities investigate the company’s former China head. | As AstraZeneca faces an ...
AstraZeneca turned down an offer of nearly £80mn in UK state support when it abruptly cancelled plans for a £450mn vaccine manufacturing site near Liverpool, according to people briefed on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results